Clinical trials
Completed Phase 2 trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 14 |
| 2023 | 11 |
| 2024 | 5 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 83 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 8 |
| Aga Khan University | 6 |
| Khyber Medical University Peshawar | 6 |
| Pakistan Institute of Living and Learning | 5 |
| Jinnah Postgraduate Medical Centre | 3 |
| University of Karachi | 3 |
| Ziauddin University | 3 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Dow University of Health Sciences | 2 |
| Islamabad Medical and Dental College | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 3 |
| Psychotic Disorders | 3 |
| COVID-19 | 2 |
| Constipation | 2 |
| Depression, Postpartum | 2 |
| Dyslipidemias | 2 |
| Hemorrhage | 2 |
| Intestinal Diseases | 2 |
| Melanosis | 2 |
| Nausea | 2 |
Trials
Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.